X4 Pharmaceuticals, Inc (XFOR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $109k
- Aug 12 · No plan
- Form 4 sales
- 100
- On record
- Form 144 notices
- 20
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJan 24 2025
Sold 22,258 shares at $0.45 ($10k)
DiBiase Mary, Chief Operating Officer
No 10b5-1 planSold 4.3% of holdings ($231k position)490,980 shares left6x usual sizeFiling
- 2 Form 4 saleNo planJan 24 same day
Sold 29,159 shares at $0.45 ($13k)
Baldry Mark, Chief Commercial Officer
No 10b5-1 planSold 23.7% of holdings ($55k position)94,123 shares leftFiling
- 3 Form 4 saleUnusualJan 24 same day
Sold 74,773 shares at $0.45 ($34k)
Mostafa Adam S., Chief Financial Officer
No 10b5-1 planSold 100% of holdings ($34k position)0 shares left2.7x usual sizeFiling
- 4 Form 4 saleNo planJan 24 same day
Sold 76,473 shares at $0.45 ($34k)
Ragan Paula, President and CEO
No 10b5-1 planSold 6.6% of holdings ($524k position)1.1M shares left2.4x usual sizeFiling
- 5 Form 4 saleNo planMay 12 +473 days
Sold 16,961 shares at $4.29 ($73k)
Kirske David, Chief Financial Officer
No 10b5-1 planSold 8.8% of holdings ($829k position)176,293 shares leftFirst sale on recordFiling
- 6 Form 4 saleNo planJun 30 +49 days
Sold 8,543 shares at $4.26 ($36k)
Kirske David, Chief Financial Officer
No 10b5-1 planSold 4.8% of holdings ($751k position)167,750 shares leftFiling
- 7 Form 4 saleNo planAug 12 +43 days
Sold 47,436 shares at $4.44 ($211k)
Craig Adam R, Executive Chairman
No 10b5-1 planSold 12.6% of holdings ($1.7M position)328,651 shares leftFirst sale on recordFiling
- 8 Form 4 saleNo planAug 12 same day
Sold 24,576 shares at $4.44 ($109k)
Volpone John, President
No 10b5-1 planSold 8.5% of holdings ($1.3M position)265,305 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (120)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Volpone John | President | Form 4 sale | 24,576 | $109k | 8.5% | No plan | SEC |
| Aug 12, 2026 | Craig Adam R | Executive Chairman | Form 4 sale | 47,436 | $211k | 12.6% | No plan | SEC |
| Jun 30, 2026 | Kirske David | Chief Financial Officer | Form 4 sale | 8,543 | $36k | 4.8% | No plan | SEC |
| May 12, 2026 | Kirske David | Chief Financial Officer | Form 4 sale | 16,961 | $73k | 8.8% | No plan | SEC |
| Jan 24, 2025 | Ragan Paula | President and CEO | Form 4 sale | 76,473 | $34k | 6.6% | No plan | SEC |
| Jan 24, 2025 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 74,773 | $34k | 100.0% | Unusual | SEC |
| Jan 24, 2025 | Baldry Mark | Chief Commercial Officer | Form 4 sale | 29,159 | $13k | 23.7% | No plan | SEC |
| Jan 24, 2025 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 22,258 | $10k | 4.3% | Unusual | SEC |
| Jan 24, 2025 | Arbet-Engels Christophe | Chief Medical Officer | Form 4 sale | 11,624 | $5k | 45.0% | Unusual | SEC |
| Nov 15, 2024 | Ragan Paula | President and CEO | Form 4 sale | 31,897 | $12k | 3.1% | No plan | SEC |
| Oct 15, 2024 | Ragan Paula | President and CEO | Form 4 sale | 31,897 | $18k | 3.0% | No plan | SEC |
| Oct 7, 2024 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 230,645 | $127k | 100.0% | Unusual | SEC |
| Oct 7, 2024 | Baldry Mark | Chief Commercial Officer | Form 4 sale | 11,127 | $6k | 18.7% | No plan | SEC |
| Oct 7, 2024 | Ragan Paula | President and CEO | Form 4 sale | 239,436 | $132k | 18.5% | Unusual | SEC |
| Oct 7, 2024 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 67,695 | $39k | 13.0% | Unusual | SEC |
| Oct 7, 2024 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 76,920 | $43k | 16.5% | Unusual | SEC |
| Sep 9, 2024 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 2,642 | $2k | 0.9% | No plan | SEC |
| Mar 11, 2024 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 14,235 | $13k | 5.7% | No plan | SEC |
| Mar 11, 2024 | Ragan Paula | President and CEO | Form 4 sale | 49,678 | $44k | 6.1% | Unusual | SEC |
| Mar 11, 2024 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 52,500 | $46k | 100.0% | Unusual | SEC |
| Mar 11, 2024 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 15,409 | $14k | 5.0% | Unusual | SEC |
| Feb 12, 2024 | Taveras Arthur | Officer | Form 144 notice | 787 | $763 | Notice | SEC | |
| Feb 12, 2024 | Mostafa Adam S. | Officer | Form 144 notice | 27,721 | $27k | Notice | SEC | |
| Feb 12, 2024 | DiBiase Mary | Officer | Form 144 notice | 3,683 | $4k | Notice | SEC | |
| Feb 12, 2024 | Ragan Paula | Officer | Form 144 notice | 21,695 | $21k | Notice | SEC | |
| Feb 12, 2024 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 3,683 | $4k | 1.2% | No plan | SEC |
| Feb 12, 2024 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 787 | $795 | 0.3% | No plan | SEC |
| Feb 12, 2024 | Ragan Paula | President and CEO | Form 4 sale | 21,695 | $22k | 2.6% | Unusual | SEC |
| Feb 12, 2024 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 27,721 | $28k | 34.6% | Unusual | SEC |
| Nov 3, 2023 | Ragan Paula | President and CEO | Form 4 sale | 239,437 | $182k | 22.3% | Unusual | SEC |
| Nov 3, 2023 | Ragan Paula | Officer | Form 144 notice | 39,906 | $32k | Notice | SEC | |
| Nov 1, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 230,645 | $168k | 74.2% | Unusual | SEC |
| Nov 1, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 67,695 | $49k | 17.9% | Unusual | SEC |
| Nov 1, 2023 | Baldry Mark | Chief Commercial Officer | Form 4 sale | 10,257 | $7k | 29.4% | Routine | SEC |
| Nov 1, 2023 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 67,695 | $49k | 21.4% | Routine | SEC |
| Nov 1, 2023 | Ragan Paula | Officer | Form 144 notice | 199,531 | $158k | Notice | SEC | |
| Nov 1, 2023 | DiBiase Mary | Officer | Form 144 notice | 67,695 | $54k | Notice | SEC | |
| Nov 1, 2023 | Taveras Arthur | Affiliate | Form 144 notice | 67,695 | $54k | Notice | SEC | |
| Nov 1, 2023 | Baldry Mark | Officer | Form 144 notice | 10,257 | $8k | Notice | SEC | |
| Nov 1, 2023 | Mostafa Adam S. | Officer | Form 144 notice | 230,645 | $182k | Notice | SEC | |
| Sep 8, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 2,642 | $3k | 1.8% | No plan | SEC |
| Sep 8, 2023 | DiBiase Mary | Officer | Form 144 notice | 2,642 | $3k | Notice | SEC | |
| Aug 10, 2023 | Stewart Murray | Interim Chief Medical Officer | Form 4 sale | 130,056 | $138k | 47.0% | Unusual | SEC |
| Jun 30, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 464 | $877 | 0.3% | No plan | SEC |
| Jun 30, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 2,641 | $5k | 3.2% | No plan | SEC |
| Jun 30, 2023 | DiBiase Mary | Officer | Form 144 notice | 464 | $878 | Notice | SEC | |
| Jun 30, 2023 | Mostafa Adam S. | Officer | Form 144 notice | 2,641 | $5k | Notice | SEC | |
| Jun 23, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 857 | $2k | 0.6% | No plan | SEC |
| Jun 23, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,417 | $10k | 6.1% | No plan | SEC |
| Jun 23, 2023 | Ragan Paula | President and CEO | Form 4 sale | 6,724 | $13k | 1.2% | No plan | SEC |
| Jun 23, 2023 | DiBiase Mary | Officer | Form 144 notice | 857 | $2k | Notice | SEC | |
| Jun 23, 2023 | Ragan Paula | Officer | Form 144 notice | 6,724 | $13k | Notice | SEC | |
| Jun 23, 2023 | Mostafa Adam S. | Officer | Form 144 notice | 5,417 | $11k | Notice | SEC | |
| Jun 15, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 857 | $2k | 0.6% | No plan | SEC |
| Jun 15, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,417 | $12k | 5.8% | No plan | SEC |
| Jun 15, 2023 | Ragan Paula | President and CEO | Form 4 sale | 6,724 | $15k | 1.2% | No plan | SEC |
| Jun 15, 2023 | Ragan Paula | Officer, President and CEO | Form 144 notice | 6,724 | $15k | Notice | SEC | |
| Jun 15, 2023 | DiBiase Mary | Officer | Form 144 notice | 857 | $2k | Notice | SEC | |
| Jun 15, 2023 | Mostafa Adam S. | Officer | Form 144 notice | 5,417 | $12k | Notice | SEC | |
| May 31, 2023 | Ragan Paula | President and CEO | Form 4 sale | 6,292 | $12k | 1.1% | No plan | SEC |
| May 31, 2023 | Ragan Paula | Officer, President and CEO | Form 144 notice | 6,292 | $12k | Notice | SEC | |
| Mar 10, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 18,192 | $15k | 10.6% | Unusual | SEC |
| Mar 10, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 52,500 | $44k | 35.9% | Unusual | SEC |
| Mar 10, 2023 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 16,806 | $14k | 16.3% | Plan not stated | SEC |
| Mar 10, 2023 | Ragan Paula | President and CEO | Form 4 sale | 49,678 | $42k | 8.1% | Unusual | SEC |
| Feb 13, 2023 | Taveras Arthur | Chief Scientific Officer | Form 4 sale | 928 | $863 | 0.9% | Plan not stated | SEC |
| Feb 13, 2023 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 4,348 | $4k | 2.5% | Plan not stated | SEC |
| Feb 13, 2023 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 27,721 | $26k | 15.9% | Unusual | SEC |
| Feb 13, 2023 | Ragan Paula | President and CEO | Form 4 sale | 21,695 | $20k | 3.4% | Unusual | SEC |
| Aug 17, 2022 | Meisner Derek M | Chief Legal Officer | Form 4 sale | 8,334 | 5.4% | Plan not stated | SEC | |
| Aug 17, 2022 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 1,713 | 1.0% | Plan not stated | SEC | |
| Aug 17, 2022 | Ragan Paula | President and CEO | Form 4 sale | 13,448 | 2.1% | Unusual | SEC | |
| Aug 17, 2022 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 10,834 | 5.9% | Plan not stated | SEC | |
| Jun 30, 2022 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 2,641 | 1.4% | Plan not stated | SEC | |
| Jun 30, 2022 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 1,578 | 0.9% | Plan not stated | SEC | |
| Jun 24, 2022 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,416 | 2.8% | Plan not stated | SEC | |
| Jun 24, 2022 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 856 | 0.5% | Plan not stated | SEC | |
| Jun 24, 2022 | Ragan Paula | President and CEO | Form 4 sale | 6,724 | 1.0% | Plan not stated | SEC | |
| Jun 24, 2022 | Meisner Derek M | Chief Legal Officer | Form 4 sale | 4,166 | 2.6% | Plan not stated | SEC | |
| Jun 16, 2022 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,416 | 2.7% | Plan not stated | SEC | |
| Jun 16, 2022 | Ragan Paula | President and CEO | Form 4 sale | 6,724 | 1.0% | Plan not stated | SEC | |
| Jun 16, 2022 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 856 | 0.5% | Plan not stated | SEC | |
| Jun 16, 2022 | Meisner Derek M | Chief Legal Officer | Form 4 sale | 4,166 | 2.6% | Plan not stated | SEC | |
| Jun 3, 2022 | Ragan Paula | President and CEO | Form 4 sale | 6,292 | $8k | 0.9% | Plan not stated | SEC |
| Feb 11, 2022 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 27,721 | 22.9% | Unusual | SEC | |
| Feb 11, 2022 | Meisner Derek M | Chief Legal Officer | Form 4 sale | 15,909 | 21.9% | Plan not stated | SEC | |
| Feb 11, 2022 | DiBiase Mary | Chief Operating Officer | Form 4 sale | 12,545 | 13.9% | Plan not stated | SEC | |
| Feb 11, 2022 | Ragan Paula | President and CEO | Form 4 sale | 21,695 | 4.6% | Unusual | SEC | |
| Feb 11, 2022 | Cadavid Diego | Chief Medical Officer | Form 4 sale | 928 | 11.5% | Plan not stated | SEC | |
| Aug 17, 2021 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 10,832 | $55k | 8.2% | Plan not stated | SEC |
| Aug 17, 2021 | Meisner Derek M | General Counsel | Form 4 sale | 8,332 | $42k | 10.3% | Plan not stated | SEC |
| Aug 17, 2021 | Ragan Paula | President and CEO | Form 4 sale | 13,448 | $69k | 2.8% | Unusual | SEC |
| Jul 15, 2021 | Ragan Paula | President and CEO | Form 4 sale | 13,448 | $78k | 2.7% | Unusual | SEC |
| Jun 30, 2021 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 2,641 | $18k | 2.0% | Plan not stated | SEC |
| Jun 24, 2021 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,417 | $38k | 3.9% | Plan not stated | SEC |
| Jun 24, 2021 | Meisner Derek M | General Counsel | Form 4 sale | 4,166 | $29k | 4.9% | Plan not stated | SEC |
| Jun 15, 2021 | Meisner Derek M | General Counsel | Form 4 sale | 4,166 | $33k | 5.4% | Plan not stated | SEC |
| Jun 15, 2021 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 5,417 | $42k | 4.2% | Plan not stated | SEC |
| Jun 2, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $23k | 0.6% | Plan not stated | SEC |
| Jun 1, 2021 | Ragan Paula | President and CEO | Form 4 sale | 4,104 | $39k | 1.0% | Plan not stated | SEC |
| May 3, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $20k | 0.6% | Plan not stated | SEC |
| Apr 5, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $22k | 0.6% | Plan not stated | SEC |
| Mar 2, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $23k | 0.9% | Plan not stated | SEC |
| Feb 2, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $19k | 0.9% | Plan not stated | SEC |
| Jan 5, 2021 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $17k | 0.9% | Plan not stated | SEC |
| Dec 23, 2020 | Ragan Paula | President and CEO | Form 4 sale | 4,800 | $34k | 1.7% | Plan not stated | SEC |
| Oct 5, 2020 | Ragan Paula | President and CEO | Form 4 sale | 1,797 | $13k | 0.6% | Plan not stated | SEC |
| Oct 2, 2020 | Ragan Paula | President and CEO | Form 4 sale | 603 | $4k | 0.2% | Plan not stated | SEC |
| Sep 21, 2020 | Mostafa Adam S. | Chief Financial Officer | Form 4 sale | 10,834 | $77k | 26.8% | Unusual | SEC |
| Sep 9, 2020 | Skerlj Renato | Chief Scientific Officer | Form 4 sale | 5,834 | $47k | 12.2% | Plan not stated | SEC |
| Sep 9, 2020 | Ragan Paula | President and CEO | Form 4 sale | 8,840 | $71k | 3.0% | Unusual | SEC |
| Sep 9, 2020 | Meisner Derek M | General Counsel | Form 4 sale | 8,334 | $67k | 33.3% | Unusual | SEC |
| Sep 2, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $19k | 0.8% | Plan not stated | SEC |
| Aug 3, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $18k | 1.1% | Plan not stated | SEC |
| Jul 2, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $22k | 1.1% | Plan not stated | SEC |
| Jun 30, 2020 | Mostafa Adam S. | Officer | Form 4 sale | 1,725 | $16k | 16.3% | Plan not stated | SEC |
| Jun 3, 2020 | Ragan Paula | President and CEO | Form 4 sale | 16,382 | $144k | 7.1% | Unusual | SEC |
| May 4, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $21k | 1.0% | Plan not stated | SEC |
| Apr 2, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $20k | 1.0% | Plan not stated | SEC |
| Mar 2, 2020 | Ragan Paula | President and CEO | Form 4 sale | 2,400 | $26k | 1.0% | Plan not stated | SEC |